Leidos Names Theodore Tanner Jr. CTO

Leidos named Theodore Ted Tanner Jr. as chief technology officer effective Jan. 5, 2026, succeeding Jim Carlini (CTO since 2019), who will remain as a senior advisor on national security; Tanner joins from BigBear.ai where he served as chief technology and strategy officer. CEO Tom Bell said Tanner’s record of delivering disruptive technology to defense, government and healthcare customers aligns with Leidos’ capabilities and its NorthStar 2030 growth priorities. The move signals continuity in Leidos’ national-security-focused technology leadership and an emphasis on deep-technology execution to support its defense, government and healthcare contracts.

Analysis

Leidos announced Theodore "Ted" Tanner Jr. will become chief technology officer effective Jan. 5, 2026, succeeding Jim Carlini, who has served as CTO since 2019 and will remain as a senior advisor to CEO Tom Bell. Tanner joins from BigBear.ai where he served as chief technology and strategy officer and has a record of delivering deep-technology solutions to defense, government and healthcare customers.

CEO Tom Bell said Tanner's entrepreneurial creativity paired with execution discipline aligns with Leidos' capabilities and its NorthStar 2030 growth priorities, signaling an explicit strategic emphasis on technology-led growth. The appointment reinforces themes of Technology & Innovation and Infrastructure & Defense and should be viewed as management succession planning intended to preserve competitive positioning on government and defense contracts.

Market signals show mildly positive sentiment (score 0.15) and low market impact (score 0.12), with LDOS-specific sentiment at 0.2, indicating investors view the news favorably but expect limited immediate share-price movement. Key risks are execution and integration of Tanner's agenda; the appointment becomes materially positive only if followed by measurable contract wins, product milestones or clear progress against NorthStar 2030 objectives.

Key Decisions for Investors

• Maintain a modestly constructive stance on LDOS given governance continuity and strategic alignment with NorthStar 2030, but avoid materially increasing exposure until Tanner's impact is evidenced by operational milestones
• Monitor near-term company releases for technology-led contract wins, R&D milestones or organizational changes that validate Tanner's ability to accelerate defense, government and healthcare offerings and reprice the position accordingly
• Do not trade expecting an immediate large market move given the low market-impact signal; incorporate this appointment into a medium-term thesis and consider hedges if portfolio sensitivity to execution risk is high